Next-generation PLpro inhibitor for SARS-CoV-2 divulged
english science
Researchers from Sunshine Biopharma Inc. and the University of Arizona reported the discovery and preclinical characterization of MR-1-114, a noncovalent inhibitor of the SARS-CoV-2 papain-like protease (PLpro). 2026-05-11 13:00:00
শেহতীয়া বাতৰি আৰু শিৰোনাম
Researchers from Sunshine Biopharma Inc. and the University of Arizona reported the discovery and preclinical characterization of MR-1-114, ...
বাতৰি